''In another informative Clinical Trials Science Forum in May, ACW CMO Dr Dana Hilt and guest
experts explored the unique properties of Xanamem for the potential treatment of cognitive
impairment in multiple diseases. Click here to view the video recording''.
Also,the trial participant side of things is gearing up in Australia and America.
''In another informative Clinical Trials Science Forum in May,...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.001(4.35%) |
Mkt cap ! $76.25M | |||
| Open | High | Low | Value | Volume |
| 2.3¢ | 2.4¢ | 2.2¢ | $91.97K | 3.970M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 844295 | 2.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.4¢ | 4548723 | 10 |
View Market Depth
| Last trade - 14.30pm 01/07/2025 (20 minute delay) ? |
| ACW (ASX) Chart |